Market Cap ₹452 Cr.
Stock P/E -5.2
P/B -3.3
Current Price ₹346.3
Book Value ₹ -104.7
Face Value 10
52W High ₹398.6
Dividend Yield 0%
52W Low ₹ 304
Kaya Ltd is an totally India-based agency, which is engaged in clinical practice activities. The Company gives healthcare aesthetics, beauty and personal care services and products in India and abroad. It offers medical services through numerous forms of system, together with surgical lasers, pores and skin remedy appliances, and system and home equipment for treatment of acne. It operates thru Skin Care phase. Its geographical segments include Middle East and India. It consists of Kaya Skin clinics, third party stores and skin bars in India. The Company additionally operates Kaya Skin clinics in the Middle East. Its skin care services consist of Pigmentation Reduction System, Age Arrest System, Kaya Hairfree Gentle Touch, Kaya Bridal and Beauty Facial. Its hair care services include Kaya Hair Health System, Shampoo, Leave On Gel/Lotion, Kaya Targeted Root Regen System. It makes use of diverse product sorts, along with cleansers, toners, moisturizers, each day regimes and treatments.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 83 | 91 | 83 | 93 | 91 | 100 | 93 | 106 | 101 | 102 |
| Other Income | 6 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 4 |
| Total Income | 89 | 93 | 85 | 94 | 92 | 102 | 93 | 107 | 102 | 107 |
| Total Expenditure | 74 | 82 | 105 | 98 | 88 | 98 | 117 | 93 | 89 | 90 |
| Operating Profit | 15 | 11 | -20 | -5 | 4 | 4 | -24 | 14 | 13 | 16 |
| Interest | 4 | 4 | 4 | 7 | 6 | 6 | 17 | 8 | 9 | 9 |
| Depreciation | 15 | 15 | 17 | 14 | 15 | 15 | 16 | 16 | 16 | 16 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -4 | -8 | -41 | -26 | -17 | -18 | -56 | -10 | -12 | -8 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -4 | -8 | -41 | -26 | -17 | -18 | -56 | -10 | -12 | -8 |
| Adjustments | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 |
| Profit After Adjustments | -5 | -8 | -42 | -26 | -17 | -18 | -56 | -10 | -11 | -8 |
| Adjusted Earnings Per Share | -3.6 | -6.4 | -31.8 | -19.7 | -12.7 | -13.6 | -43.1 | -7.9 | -8.8 | -6.3 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 143 | 290 | 332 | 370 | 409 | 400 | 421 | 393 | 275 | 324 | 377 | 402 |
| Other Income | 19 | 81 | 15 | 12 | 11 | 10 | 4 | 9 | 15 | 12 | 5 | 7 |
| Total Income | 162 | 372 | 348 | 382 | 420 | 410 | 425 | 402 | 290 | 336 | 381 | 409 |
| Total Expenditure | 151 | 274 | 296 | 352 | 425 | 398 | 406 | 338 | 248 | 297 | 363 | 389 |
| Operating Profit | 11 | 97 | 52 | 30 | -4 | 12 | 19 | 64 | 42 | 39 | 19 | 19 |
| Interest | 2 | 4 | 4 | 4 | 5 | 7 | 9 | 22 | 19 | 21 | 42 | 43 |
| Depreciation | 10 | 9 | 12 | 17 | 20 | 24 | 29 | 75 | 60 | 86 | 93 | 64 |
| Exceptional Income / Expenses | -11 | -37 | -5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -12 | 46 | 32 | 9 | -30 | -19 | -19 | -33 | -37 | -68 | -116 | -86 |
| Provision for Tax | 4 | 9 | 0 | 0 | -3 | -0 | -6 | 21 | 0 | 0 | 0 | 0 |
| Profit After Tax | -16 | 37 | 32 | 9 | -27 | -19 | -14 | -54 | -37 | -68 | -116 | -86 |
| Adjustments | 0 | 0 | 0 | -0 | -2 | -2 | -2 | -0 | -1 | -1 | -0 | 0 |
| Profit After Adjustments | -16 | 37 | 32 | 9 | -29 | -21 | -16 | -54 | -38 | -69 | -116 | -85 |
| Adjusted Earnings Per Share | 0 | 0 | 0 | 6.8 | -22.2 | -16.2 | -12.2 | -41.7 | -29.1 | -52.7 | -89.2 | -66.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 16% | -1% | -1% | 10% |
| Operating Profit CAGR | -51% | -33% | 10% | 6% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -5% | 9% | -10% | NA% |
| ROE Average | 0% | -106% | -75% | -37% |
| ROCE Average | -122% | -65% | -41% | -16% |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 66 | 83 | 235 | 251 | 229 | 210 | 158 | 82 | 54 | -2 | -104 |
| Minority's Interest | 0 | 0 | 0 | 0 | 2 | 2 | 1 | 1 | 0 | 1 | 1 |
| Borrowings | 113 | 113 | 0 | 0 | 19 | 14 | 19 | 22 | 29 | 79 | 142 |
| Other Non-Current Liabilities | 13 | 8 | 15 | 18 | -14 | -12 | -9 | 119 | 103 | 88 | 82 |
| Total Current Liabilities | 227 | 125 | 129 | 142 | 190 | 137 | 180 | 189 | 182 | 196 | 249 |
| Total Liabilities | 420 | 329 | 378 | 412 | 425 | 351 | 349 | 413 | 368 | 361 | 370 |
| Fixed Assets | 289 | 87 | 112 | 149 | 193 | 201 | 206 | 303 | 279 | 240 | 217 |
| Other Non-Current Assets | 19 | 18 | 31 | 32 | 46 | 30 | 29 | 15 | 12 | 16 | 11 |
| Total Current Assets | 111 | 224 | 235 | 231 | 187 | 120 | 115 | 95 | 78 | 106 | 143 |
| Total Assets | 420 | 329 | 378 | 412 | 425 | 351 | 349 | 413 | 368 | 361 | 370 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 7 | 25 | 14 | 28 | 27 | 14 | 20 | 19 | 7 | 12 | 20 |
| Cash Flow from Operating Activities | 34 | 92 | 29 | 5 | -8 | -12 | 22 | 47 | 32 | 30 | 63 |
| Cash Flow from Investing Activities | -132 | -11 | -17 | -6 | -42 | 24 | -28 | -12 | 4 | -35 | -40 |
| Cash Flow from Financing Activities | 115 | -73 | -0 | -0 | 33 | -7 | 5 | -47 | -31 | 12 | -18 |
| Net Cash Inflow / Outflow | 18 | 7 | 13 | -2 | -16 | 6 | -1 | -12 | 5 | 7 | 5 |
| Closing Cash & Cash Equivalent | 25 | 14 | 28 | 28 | 14 | 20 | 19 | 7 | 12 | 20 | 25 |
| # | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0 | 0 | 0 | 6.82 | -22.23 | -16.22 | -12.22 | -41.66 | -29.1 | -52.69 | -89.15 |
| CEPS(Rs) | -3.11 | 26.25 | 0 | 20 | -5.54 | 4.14 | 11.74 | 16.19 | 17.4 | 13.75 | -17.58 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 0 | 0 | 0 | 194.12 | 174.73 | 159.66 | 119.02 | 60.61 | 41.7 | -2.17 | -81.58 |
| Core EBITDA Margin(%) | -5.58 | 5.46 | 11.01 | 4.78 | -3.87 | 0.56 | 3.56 | 14.15 | 9.8 | 8.32 | 3.73 |
| EBIT Margin(%) | -6.75 | 17.36 | 10.73 | 3.57 | -5.99 | -3.12 | -2.36 | -2.8 | -6.7 | -14.57 | -19.84 |
| Pre Tax Margin(%) | -8.31 | 15.88 | 9.57 | 2.39 | -7.28 | -4.82 | -4.59 | -8.4 | -13.61 | -20.98 | -30.86 |
| PAT Margin (%) | -11.04 | 12.88 | 9.57 | 2.39 | -6.66 | -4.72 | -3.27 | -13.76 | -13.61 | -20.98 | -30.86 |
| Cash Profit Margin (%) | -3.88 | 16.14 | 13.05 | 6.97 | -1.76 | 1.35 | 3.64 | 5.38 | 8.27 | 5.55 | -6.1 |
| ROA(%) | -4.61 | 9.99 | 8.99 | 2.24 | -6.51 | -4.87 | -3.93 | -14.21 | -9.58 | -18.64 | -31.81 |
| ROE(%) | -84.05 | 50.12 | 20.9 | 3.76 | -11.41 | -8.68 | -7.57 | -46.11 | -55.98 | -263.21 | 0 |
| ROCE(%) | -4.89 | 22.58 | 16.56 | 5.43 | -9.62 | -5.06 | -4.65 | -7.24 | -18.27 | -53.94 | -121.62 |
| Receivable days | 1.74 | 0.7 | 0.45 | 0.95 | 1.57 | 2.63 | 3.96 | 4.89 | 5.61 | 4.02 | 3.57 |
| Inventory Days | 56.42 | 31.36 | 31.97 | 42.64 | 45.91 | 42.46 | 37.46 | 36.76 | 42.24 | 30.75 | 27.33 |
| Payable days | 860.55 | 233.35 | 287.81 | 371.38 | 355.46 | 1585.5 | 1523.06 | 1058.8 | 1518.93 | 1829.08 | 1177.87 |
| PER(x) | 0 | 0 | 0 | 126.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 4.44 | 4.46 | 6.54 | 6.01 | 1.84 | 7.11 | -161.21 | -3.1 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 1.23 | 0.4 | -0.08 | 2.93 | 2.51 | 3.41 | 2.26 | 0.43 | 1.49 | 1.6 | 1.11 |
| EV/Core EBITDA(x) | 15.93 | 1.2 | -0.53 | 35.93 | -229.92 | 115.84 | 49.7 | 2.61 | 9.83 | 13.37 | 22.59 |
| Net Sales Growth(%) | 10.57 | 102.52 | 14.47 | 11.32 | 10.59 | -2.12 | 5.12 | -6.57 | -30.07 | 17.82 | 16.29 |
| EBIT Growth(%) | -273.48 | 620.66 | -29.28 | -62.99 | -285.89 | 48.99 | 20.42 | -10.61 | -67.36 | -156.16 | -58.39 |
| PAT Growth(%) | -5553.57 | 336.2 | -15 | -72.13 | -407.73 | 30.63 | 27.27 | -293.44 | 30.86 | -81.66 | -71.08 |
| EPS Growth(%) | 0 | 0 | 0 | 0 | -425.87 | 27.04 | 24.66 | -240.91 | 30.15 | -81.09 | -69.19 |
| Debt/Equity(x) | 2.77 | 1.37 | 0 | 0 | 0.13 | 0.12 | 0.22 | 0.37 | 0.66 | -30.33 | -1.33 |
| Current Ratio(x) | 0.49 | 1.79 | 1.83 | 1.62 | 0.98 | 0.87 | 0.64 | 0.5 | 0.43 | 0.54 | 0.57 |
| Quick Ratio(x) | 0.38 | 1.59 | 1.58 | 1.25 | 0.72 | 0.56 | 0.4 | 0.31 | 0.28 | 0.4 | 0.45 |
| Interest Cover(x) | -4.34 | 11.72 | 9.23 | 3.04 | -4.64 | -1.84 | -1.06 | -0.5 | -0.97 | -2.27 | -1.8 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0.03 | 0.02 | 0.04 | 0.2 | 0.09 | 0.19 | 0.43 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 59.93 | 59.93 | 59.93 | 59.93 | 59.93 | 59.93 | 59.93 | 59.93 | 59.93 | 59.79 |
| FII | 0.75 | 0.87 | 0.74 | 0.74 | 0.73 | 0.73 | 0.8 | 0.81 | 0.73 | 0.74 |
| DII | 1.34 | 1.53 | 1.53 | 1.38 | 1.38 | 1.34 | 1.34 | 1.34 | 1.34 | 1.97 |
| Public | 37.98 | 37.67 | 37.8 | 37.96 | 37.97 | 38.01 | 37.93 | 37.93 | 38.01 | 37.5 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 |
| FII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
| Public | 0.5 | 0.49 | 0.49 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.49 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
